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Abstract
In this work, we develop a Bayesian approach to perform selection of predictors that are linked 
within a network. We achieve this by combining a sparse regression model relating the predictors 
to a response variable with a graphical model describing conditional dependencies among the 
predictors. The proposed method is well-suited for genomic applications since it allows the 
identification of pathways of functionally related genes or proteins which impact an outcome of 
interest. In contrast to previous approaches for network-guided variable selection, we infer the 
network among predictors using a Gaussian graphical model and do not assume that network 
information is available a priori. We demonstrate that our method outperforms existing methods in 
identifying network-structured predictors in simulation settings, and illustrate our proposed model 
with an application to inference of proteins relevant to glioblastoma survival.
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1. Introduction
In this work, we address the problem of identifying predictors that are both relevant to a 
response variable of interest and functionally related to one another. In the context of 
genomic studies, the mechanism for an effect on an outcome such as a quantitative 
phenotype or disease risk is typically a coordinated change within a pathway, and the impact 
of a single gene may not be strong. In this setting, our proposed inference method can 
highlight pathways or regulatory networks which impact the response. To uncover these 
relationships, we develop a Bayesian modeling approach which favors selection of variables 
that are not only relevant to the outcome of interest but also linked within a conditional 
dependence network. Unlike previous approaches which incorporate network information 
into variable selection, we do not assume that the graph relating the predictors is known. 
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Instead, we develop a joint model to learn both the set of relevant predictors and estimate a 
graphical model describing their interdependence.
There is increasing evidence from genome-wide association studies that complex traits are 
governed by a large number of genomic variants with small effects, making them difficult to 
detect in the absence of very large sample sizes [4, 5, 6]. Importantly, however, genes do not 
act in isolation: instead, they affect phenotypes indirectly through complex molecular 
networks. One of the primary motivations for incorporating network information into 
regression modeling is that coordinated weak effects are often grouped into pathways [7], so 
accounting for the relationships among the predictors has the potential to increase power to 
detect true associations. Although there are many databases which provide information on 
biochemical relationships under normal conditions, the available reference networks may be 
incomplete or inappropriate for the experimental condition or set of subjects under study. 
Rather than assuming that a relevant prior network is available, it is therefore of interest to 
infer one directly from the data at hand. Learning networks from high-throughput data relies 
on the assumption that genes, proteins, or metabolites which have similar patterns of 
abundance are likely to have an underlying biological relationship. Although the inferred 
connections are based on correlations rather than direct experimental observation, 
approaches for network reconstruction based on these assumptions have been shown to be 
accurate in learning regulatory or functional pathways [1]. In particular, co-expression 
networks derived from microarray data have been shown to correspond quite well to known 
functional organization across all categories of genes [2], and it has been demonstrated that 
correlation-based methods perform well in recovering protein signaling networks from flow 
cytometry data [3].
A number of recent papers use a known network describing the relationships among 
predictors to inform variable selection. Li and Li [8, 9] propose a regularized regression 
approach, combining a lasso penalty to encourage sparsity with a penalty based on the graph 
Laplacian to encourage smoothness of the coefficients with respect to a graph. Pan et al. 
[10] develop a single penalty using the weighted Lγ norm of the coefficients of neighboring 
nodes which more strongly encourages grouped variable selection. Huang et al. [11] 
combine a minimax concave penalty with a quadratic Laplacian penalty to achieve 
consistency in variable selection. Most recently, Kim et al. [12] propose a penalty structure 
which encourages the selection of neighboring nodes but avoids the assumption that their 
coefficients should be similar.
In the Bayesian framework, Li and Zhang [13] and Stingo and Vannucci [14] incorporate a 
graph structure in the Markov random field (MRF) prior on indicators of variable selection, 
encouraging the joint selection of predictors with known relationships. Stingo et al. [15] and 
Peng et al. [16] propose selection of both known pathways and genes within them, using 
previously established pathway membership information and the network structure within 
each pathway to guide the selection. Hill et al. [17] develop an empirical Bayes approach 
which incorporates existing pathway information through priors that reflect a preference for 
the selection of variables from within a certain number of pathways or with a certain average 
pairwise distance within a pathway. Zhou and Zheng [18] develop a Bayesian analogue to 
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the penalized regression approaches using the graph Laplacian, with an extension to allow 
uncertainty over the sign of edges in the graph.
In contrast to the above approaches which use a graph relating the variables as an input to a 
variable selection procedure, we are interested in both identifying the relevant variables and 
learning the network among them. Previous attempts at this problem include Dobra [19], 
which proposes estimating a network among relevant predictors by first performing a 
stochastic search in the regression setting to identify sets of predictors with high posterior 
probability, then applying a Bayesian model averaging approach to estimate a dependency 
network given these results. Liu et al. [20] propose a Bayesian regularization method which 
uses an extended version of the graph Laplacian as the precision matrix for a multivariate 
normal prior on the coefficients. They infer relationships among these coefficients by 
thresholding their estimated correlations. Our proposed method differs from these 
approaches in that our network is based on a Gaussian graphical model among the 
predictors, which provides a sparse and interpretable representation of the conditional 
dependencies found in the data. This is very different from a network among the 
coefficients, which provides information on which predictors have a similar effect on the 
response but not on relationships among the predictors themselves. Since we rely on a 
Gaussian graphical model to infer the network among predictors, the predictors should be 
reasonably normal. This assumption is quite common and is appropriate for many biological 
data types: in particular, RNA, protein and metabolite levels are typically normalized as a 
part of the standard data processing pipeline. Our model also accommodates the inclusion of 
non-normal fixed covariates such as age and gender.
Our modeling approach allows inference of both the relevant variables and the network 
structure linking them. Importantly, our method does not require that a network structure 
among the predictors is known a priori. Instead, we simultaneously infer a sparse network 
among the predictors and perform variable selection using this network as guidance by 
incorporating it into a prior favoring selection of connected variables. The proposed 
approach not only offers good performance in terms of selection and prediction, but also 
provides insight into the relationships among important variables and allows the 
identification of related predictors which jointly impact the response. In addition, since we 
take a Bayesian approach to the problem of joint variable and graphical model selection, we 
are able to fully account for uncertainty over both the selection of variables and of the graph. 
This is particularly important in the context of graphical model selection since in most 
applications uncertainty over the graph structure is large. In contrast, stagewise estimation 
with graph selection as the first step following by variable selection taking the inferred 
graph as fixed fails to account for this uncertainty. We find that in selecting proteins relevant 
to glioblastoma survival, the proposed joint method not only improves prediction accuracy, 
but also identifies several interacting proteins which are missed using standard Bayesian 
variable selection.
The remainder of the paper is organized as follows. In Section 2, we first provide 
background on variable selection and graphical models, then specify the details of the 
proposed model. In Section 3, we discuss posterior inference including the Markov chain 
Monte Carlo (MCMC) sampling approach and selection of the variables and edges. In 
Peterson et al. Page 3
Stat Med. Author manuscript; available in PMC 2017 March 30.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Section 4, we assess the performance of the proposed method via simulation studies. In 
Section 5, we apply the proposed method to identify a set of network-related proteins which 
impact glioblastoma survival. Finally, we conclude with a discussion in Section 6.
2. Methods
2.1. Variable selection and graphical models
The goal of variable selection is to identify the subset of predictors which are truly relevant 
to a given outcome. Selecting a sparse model can help reduce noise in estimation and 
produce more interpretable results, particularly when the true underlying model is sparse. 
This is often the case when dealing with high-throughput biological data such as gene or 
protein expression, where typically only a small number of markers out of many thousands 
assayed are believed to be associated to a disease outcome. Traditional methods for variable 
selection include forward, backward, and stepwise selection. More recently, penalized 
methods based on the lasso [21], which places an L1 penalty on the regression coefficients to 
achieve sparsity, have become popular. In the Bayesian framework, stochastic search 
variable selection [22] is a widely used variable selection approach for linear regression. In 
this method, latent indicators are used to represent variable inclusion, and the prior on the 
coefficient for a given variable is a mixture density with a “spike” at 0 if the variable is not 
included and a diffuse “slab” if the variable is included.
When dealing with related variables, we may be interested in inferring the dependencies 
among them. An undirected graph, or Markov random field, is represented by G = (V, E) 
where V is a set of vertices and E is a set of edges such that the edge (i, j) ∈ E if and only if 
(j, i) ∈ E. Undirected graphical models, which use a graph structure to represent conditional 
dependencies among variables, have the property that there is no edge between the vertices 
representing two variables if and only if the variables are independent after conditioning on 
all other variables in the data set. In the context of multivariate normal data, graphical 
models are known as Gaussian graphical models (GGMs) or covariance selection models 
[23]. In this setting, the graph structure G implies constraints on the precision matrix Ω, the 
inverse of the covariance matrix Σ. Specifically, the entry ωij = 0 if and only if the edge (i, j) 
is missing from the graph G, meaning that variables i and j are conditionally independent. 
Since graphical model estimation corresponds to estimation of a sparse version of Ω, 
regularization methods are a natural approach. In particular, the graphical lasso [24, 25, 26], 
which imposes an L1 penalty on the sum of the absolute values of the entries of Ω, is a 
popular method for achieving the desired sparsity in estimation of Ω.
In the Bayesian framework, the G-Wishart [27, 28] is the conjugate prior for Ω constrained 
by an arbitrary graph G. Even when the graph structure is known, sampling from this 
distribution poses computational difficulties since both the prior and posterior normalizing 
constants are intractable. Recent proposals addressing the challenge of G-Wishart sampling 
include Dobra et al. [29], Wang and Li [30] and Lenkoski [31]. Despite improvements in 
efficiency, the scalability of these methods is still limited. The Bayesian graphical lasso 
[32], proposed as the Bayesian analogue of the frequentist graphical lasso, uses shrinkage 
priors to allow more efficient model fitting. However, it does not model the graph structure 
directly and therefore only allows graph inference through some form of thresholding on the 
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posterior precision matrix. In previous work, we have utilized both type of priors, taking 
advantage of the Bayesian graphical lasso to integrate relevant prior information when 
inferring metabolic networks [33] and the G-Wishart when inferring multiple graphical 
models across related sample groups [34]. Here we adopt the recent approach of Wang [35] 
which avoids some of the computational issues of G-Wishart sampling (in particular, the 
need to approximate the normalizing constant) but still allows inference directly on the 
graph structure through a prior that combines a continuous spike-and-slab prior on entries of 
the precision matrix with binary latent indicators of edge inclusion. This approach allows 
scaling to several hundred variables, while previous methods based on G-Wishart sampling 
were limited to a few dozen.
2.2. Proposed joint model
Let yi represent the observed response variable and Xi represent the observed vector of p 
predictors for the ith subject, where i = 1,…, n. The Xi correspond to a potentially large set 
of related predictors, such as gene or protein abundances, of which we are interested in both 
identifying an explanatory subset and understanding their interrelation. In our modeling 
approach, we consider both the response Yn×1 and the predictors Xn×p to be random 
variables, so our likelihood is the joint distribution f(Y, X). Because we assume Y to be a 
function of X, we can factor the joint distribution into the conditional distribution of Y given 
X and the marginal distribution of X
(1)
We then define f(Y|X) as a linear regression model and f(X) as a multivariate normal 
distribution. In the model for Y|X, we include a set of m additional covariates Zi which are 
not subject to selection. These may correspond to clinical variables such as age or gender. 
We write the conditional distribution of y given X as
(2)
where α0 is the intercept term, αm×1 and βp×1 represent the respective effects of Z and X, the 
εi are iid errors, and τ2 is the error variance. Although the y in equation (2) represents a 
continuous outcome, the model can be extended in a straightforward manner to allow binary, 
multinomial, or survival responses, as discussed in Section 2.7 and in the Supplement. The 
distribution of the predictors X, which are assumed to be centered, is
(3)
where Ω = Σ−1 is the precision matrix of the multivariate normal distribution.
2.3. Prior on coefficients β
We consider the jth variable to be included in the model if its coefficient βj ≠ 0. The problem 
of variable selection therefore corresponds to the problem of inferring which βs are nonzero. 
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We follow the stochastic search variable selection approach [22] in formulating a prior on 
the coefficients β1,…, βp which allows sparse inference. To summarize the inclusion of 
predictors in the model, we introduce a vector of latent indicator variables γ. The prior for βj 
conditional on γj is a mixture of a normal density and a Dirac delta function δ0, which can be 
written as
(4)
where hβ > 0 is a fixed hyperparameter. Following the recommendation in Sha et al. [36] 
and Stingo et al. [15], hβ should be set to a value within the range of the variability of X. 
This type of mixture prior is known as a spike-and-slab prior.
2.4. Graph selection prior on Ω and G
The goal of the graph selection prior is to allow inference of a network among the predictors 
X. We take advantage of recent improvements in the scalability of Bayesian graphical model 
inference, as mentioned in Section 2.1, to infer a network among all predictors, avoiding the 
need for a separate variable screening step. Here we follow the proposal of Wang [35] in 
using a hierarchical prior which relies on latent binary indicators for edge inclusion. 
Specifically, let gij ∈ {0,1} represent the presence of edge (i,j) in the graph G, where i < j. 
The prior distribution on the precision matrix Ω from equation (3) combines an exponential 
prior on the diagonal entries with a mixture of normals on the off-diagonal entries of to 
allow the entries for selected edges to have a larger variance than that of non-selected edges:
(5)
where {C(G, ν0, ν1, λ)} is the normalizing constant, ν0 > 0 is small, ν1 > 0 is large, λ > 0, 
and I{Ω∈M+} is an indicator function which restricts the prior to the space of symmetric 
positive definite matrices. By choosing ν0 to be small, we ensure that ωij will be close to 0 
for non-selected edges. For selected edges, a large value of ν1 allows ωij to have more 
substantial magnitude. In the second level of the hierarchy, we place a prior on the edge 
inclusion indicators gij:
(6)
where C(ν0, ν1, λ, π) is a normalizing constant and π reflects the prior probability of edge 
inclusion. The parameters ν0, ν1, λ and π are all taken to be fixed. Guidance on the selection 
of these parameters is provided in Wang [35], which reports that values of νo ≥ 0.01 and ν1 
≤ 10 result in good convergence and mixing for standardized data. Wang [35] recommends 
the choice of λ = 1 but finds that the results are relatively insensitive to this choice, and 
suggests that 2/(p − 1) is a sensible setting for π. In addition, Wang [35] provides 
performance measurements under a variety of parameter combinations. Since these 
hyperparameters have an impact under our model not only on the selection of edges, but also 
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indirectly on the selection of variables, we provide sensitivity analysis for π in the 
Supplement. We find that the number of selected variables is not strongly sensitive to this 
choice.
2.5. Prior linking variable selection indicators γ to selection of the graph G
The standard prior in the Bayesian literature for the variable selection indicators γ is an 
independent Bernoulli
where λ is the prior probability of variable inclusion. Instead of an independent prior, we 
propose a prior that allows us to tie the selection of variables to the presence of edges 
relating them in the graph. To accomplish this, we rely on a Markov random field (MRF) 
prior favoring the inclusion of variables which are linked to other variables in the network. 
MRF priors have been utilized in the variable selection context by Li and Zhang [13] and 
Stingo and Vannucci [14]. However, unlike these authors, who assume that the structure of 
the network among predictors is known, we incorporate inference of the network structure. 
We express the prior for γ conditional on G as
(7)
where a and b are scalar hyperparameters and G is an adjacency matrix representation of the 
graph. In this formulation, the parameter a affects the probability of variable inclusion, with 
smaller values corresponding to sparser models. The parameter b determines how strongly 
the probability of inclusion for a variable is affected by the inclusion of its neighbors in the 
graph. As noted in Li and Zhang [13], increasing values of b may lead to a phase transition 
in which the number of included variables rises sharply. For guidance on choosing a value 
of b which corresponds to a sparse model, see Section 3.1 of Li and Zhang [13].
To summarize, our prior linking variable and edge selection reflects a preference for the 
inclusion of connected predictors in the model by incorporating a Markov random field on 
the variable selection indicators which utilizes the estimated network among predictors. The 
proposed model is therefore appropriate for data sets where the predictors which affect the 
outcome of interest are in fact connected through a network. As discussed in Section 1, this 
is the case for a broad range of biological settings where there is an interest in associating 
gene, protein, or metabolite levels to complex traits or disease risk.
2.6. Conjugate priors for error variance τ2, intercept α0, and coefficients of fixed covariates 
α
For the prior on the error variance τ2 in equation (2), we use the standard conjugate prior
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(8)
where IG is the inverse-gamma density, and a0 > 0 and b0 > 0 are fixed hyperparameters. 
For the prior on the intercept α0, we use the standard conjugate prior
(9)
where h0 is a fixed hyperparameter. For the prior on the coefficient vector α in equation (2), 
which represents the effects of additional covariates which are not subject to selection, we 
use the standard conjugate prior
(10)
where 0 is the prior mean, Im represents the m × m identity matrix, and hα > 0 is a fixed 
hyperparameter. As in the choice of hβ, we follow Sha et al. [36] and Stingo et al. [15] in 
recommending that hα should be set within the range of the variability of Z, and h0 should 
be fixed to a large value so that the prior on the intercept is vague.
2.7. Extension to survival response
To accommodate survival outcomes, we use an accelerated failure time (AFT) model as in 
Sha, Tadesse and Vannucci [37]. Let ti represent the time to event for subject i and ci 
represent the censoring time. We observe times  as well as censoring 
indicators δi = I{ti ≤ ci}. We then estimate augmented failure times yi where
(11)
We assume that the latent variables follow the linear model given in equation (2), and retain 
the prior specification as given for the standard linear model.
3. Posterior inference
The joint posterior distribution for the set of all parameters γ = {α,β, τ2, γ, Ω, G} is 
proportional to the product of the likelihood and the prior distributions
(12)
Since this joint distribution is not tractable, Markov chain Monte Carlo (MCMC) 
simulations are required to obtain a posterior sample of the parameters. However, this 
sampling may be difficult because the joint posterior space is quite complex and includes 
many dependent parameters. In particular, updates to the variable selection indicators γ 
require dimension changes for β. By integrating out some parameters and focusing on the 
remaining set, we can both simplify the sampler and reduce the number of iterations needed 
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to obtain a satisfactory posterior sample of the parameters of interest. Specifically, for both 
the linear and AFT models, we integrate out the parameters α0, α, β and τ2 to obtain a 
multivariate t-distribution for Y with degrees of freedom 2a0, mean 0, and scale 
. The joint posterior for the simplified model is then
(13)
3.1. MCMC sampling
In the MCMC sampling scheme, we include steps to update the variable selection indicators 
γ conditional on the current graph, to update the graph G and precision matrix Ω, and to 
sample the latent variables if we are in the probit or AFT setting. A brief outline of the 
sampling scheme is given below. At the top level, the sampler follows a Metropolis-
Hastings within Gibbs approach. For a full description, see the Supplement.
1. Update variable selection indicators γ. At each iteration, we propose either adding 
or removing a variable. We then accept or reject the proposed move using a 
Metropolis-Hastings approach, conditional on the currently selected graph.
2. Update the graph G and precision matrix Ω. In this step, we sample new values for 
the graph G and precision matrix Ω using the block Gibbs sampler proposed in 
Wang [35].
3. Update the latent variables Y for the probit or AFT models. For the probit model, 
this entails sampling the latent variables from a truncated multivariate normal 
distribution conditional on the current set of included variables. For the AFT 
model, we sample the augmented failure times from a truncated multivariate t-
distribution.
Beginning from an arbitrary set of initial values, we iterate until we have obtained a 
representative sample from the posterior distribution. Samples from the burn-in period, 
which are affected by the initial conditions, are discarded, and the remaining samples are 
used as the basis for inference.
3.2. Variable selection and prediction
Since the search space of possible sets of variables is quite large, any particular model may 
only be encountered a limited number of times during the MCMC sampling. For this reason, 
we focus on the marginal posterior probabilities of inclusion (PPIs) to perform variable 
selection rather than the maximum a posteriori (MAP) model, which is the single model 
with highest posterior probability. The PPI for a variable is the proportion of MCMC 
iterations after the burn-in where it is included. In order to make the final model selection, a 
threshold is typically imposed on the PPIs. Here we use the median model, which 
corresponds to a threshold of 0.5. Barbieri and Berger [38] demonstrate that the median 
model is the optimal predictive model in the context of linear regression when the predictor 
matrix X satisfies the condition that X′X is diagonal, outperforming the single model with 
the highest posterior probability.
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To perform prediction, we follow an approach similar to that given in Section 8 of [39]. 
Specifically, given a future set of covariates Zf and Xf, we predict Ŷ as the MCMC average
(14)
where T is the total number of MCMC iterations. The intercept α̂0 and coefficient vectors α̂ 
and β̂(t) are estimated as
(15)
where γ(t) is the vector of variable selection indicators from the tth MCMC iteration.
3.3. Graph selection
As the number of possible graphs is even larger than the number of possible combinations of 
variables, we adopt a similar approach for graph selection as for variable selection. Namely, 
rather than selecting the most frequently encountered graph, we select the edges marginally 
by including all edges with posterior probability of inclusion (PPI) greater than 0.5. This 
estimate is a common approach for graph selection and has been shown to perform well in 
practice [34, 35].
4. Simulation study
4.1. Performance comparison
In this simulation, we compare our proposed method to other variable selection methods in a 
regression setting with network-related predictors. We simulate the data following the 
setting given in Li and Li [8], but with reduced scale to allow computational tractability. In 
this scenario, the predictors correspond to clusters of genes consisting of a transcription 
factor and the genes it regulates. A subset of these regulatory pathways contribute to the 
outcome variable. Li and Li [8] include 4 variants on this model which allow effects of 
differing direction and magnitude. Specifically, in Model 1, genes within the same cluster 
have effects with the same sign. In Model 2, genes within the same cluster may have effects 
with opposite signs. Models 3 and 4 follow the same sign pattern but the effects have 
smaller magnitude.
In the simulation given here, we include 40 transcription factors, each of which regulates 5 
genes. This corresponds to a graph with a total of 200 edges where nodes are grouped into 
40 modules. The first 4 groups of transcription factors and the genes they regulate have 
nonzero coefficients following the same pattern as in Li and Li [8]. The complete coefficient 
vectors for each model are given in Table 1. Across all models, the number of true 
predictors is ptrue = 24 out of a total of p = 240. The expression levels X are generated from 
a multivariate normal with mean 0 and covariance Σ, where Σ is defined so that the variance 
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of the expression level for each transcription factor is 1, and the correlation of the expression 
level of a transcription factor to the expression level of each gene it regulates is 0.7. The 
error variance  is set to . The response variable y is generated from the linear 
model y = Xβ + ε where . The resulting signal-to-noise ratio (SNR) for models 
1, 2, 3, and 4 are 12.5,4.7, 7.0, and 4.5, respectively. For both the training and test data, X 
and Y were centered.
For each of the four models, 100 training samples were used for parameter estimation, and 
100 test samples were used to evaluate prediction. Variable selection and prediction were 
performed using the lasso [21], elastic net [40], network-constrained regularization [8], 
stochastic search variable selection [22] and the proposed joint graph and variable selection 
method. The first three models were fit using the Matlab software Glmnet available from 
http://web.stanford.edu/∼hastie/glmnet_matlab/. The penalty parameters were chosen via 
grid search to minimize 10-fold cross-validation error on the training data.
For both Bayesian methods, the parameter hβ, which determines the prior variance of the 
non-zero βs in equation (4), was set to the variance of the nonzero βs divided by . Since 
the data were centered, the intercept term α0 was assumed to be 0. As discussed by Smith 
[41], this is equivalent to a non-informative prior with h0 → ∞ in equation (9). The shape 
and scale parameters of the inverse gamma prior on τ2 given in equation (8) were set to a0 = 
2 and . This choice of hyperparameters leads to a prior mean for the error variance of 
, corresponding to a value of 25.5 in Models 1 and 2 and a value of 17.9 in Models 3 and 
4. The effect of varying b0, which corresponds to varying the mean of the inverse gamma 
prior, is examined in the sensitivity analysis provided in the Supplement. For the stochastic 
search Bayesian variable selection, the prior probability of edge inclusion was set to the true 
value of ptrue/p = 0.1. For the joint variable and graph selection model, we need to specify 
the parameters for the graph selection prior given in equations (5) and (6). Following the 
recommendations in Wang [35], we set ν0 = 0.1, ν1 = 10, λ = 1, and π = 2/(p − 1). We must 
also specify parameters for the Markov random field prior given in equation (7). We set the 
hyperparameter a, which controls the overall sparsity of variable selection, to -2.75, and the 
hyperparameter b, which affects the prior probability of inclusion for connected variables, to 
0.5. When b = 0 or the graph G contains no edges, the setting for a results in a prior 
probability of variable inclusion around 0.06. The nonzero value of b combined with a non-
empty graph will act to increase this. An analysis of the sensitivity of the variable selection 
to a and b is reported in the Supplement.
In running the MCMC for the Bayesian methods, the initial value for the vector of variable 
selection indicators γ was chosen to be 0. For the joint graph and variable selection method, 
the initial value for Ω was set to Ip. For both methods, we allowed 5,000 iterations of burn-
in, which were discarded, followed by 5,000 iterations used as the basis for inference. 
Variable and edge selection were based on the criterion that the posterior probability of 
inclusion was greater than 0.5.
The 5 methods were compared on the basis of sensitivity (the true positive rate of variable 
selection), specificity (1 - the false positive rate of variable selection), the Matthews 
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correlation coefficient (MCC) (a combined measure of the overall variable selection 
accuracy), the area under the ROC curve (AUC), and mean squared prediction error 
(PMSE). Since the number of true positives and true negatives are very different, sensitivity 
and specificity provide an imperfect view of variable selection accuracy. For this reason, we 
include the MCC, a single balanced metric summarizing classification performance which 
accounts for the differing numbers of true positives vs. true negatives. To assess the 
performance of variable selection across a range of model sizes, we also provide the AUC. 
Let TP represent the number of true positives (correctly identified variables), TN the number 
of true negatives (correctly rejected variables), FP the number of false positives (noise 
variables selected), and FN the number of false negatives (incorrectly rejected variables). 
We can then define the sensitivity, specificity, and MCC as
Estimation of the AUC requires computing sensitivity and specificity for varying levels of 
sparsity. For the regularization methods, the AUC was obtained by varying the L1 penalty 
parameter. For the elastic net and network-constrained regularization approaches, which 
require selection of a second penalty parameter, this parameter was chosen by performing 
10-fold cross validation at each level of the L1 penalty parameter. The AUC for the Bayesian 
methods was obtained by varying the selection threshold for the posterior probabilities of 
variable inclusion. Finally, mean squared prediction error is defined as
where n is the number of observations in the test data, Ŷ is the predicted value of Y for the 
test data, and Ytest is the true value of Y in the test data set. The resulting values are given in 
Table 2.
Based on this summary, we see that although the regularization methods (Lasso, Enet, and 
Li Li) tend to have good sensitivity, the proposed joint Bayesian method has much better 
specificity. The poor specificity of the regularization methods makes sense in the light of 
previous work demonstrating that selection of the regularization parameter using cross-
validation is optimal with respect to prediction, but tends to result in the inclusion of too 
many noise predictors [24]. We therefore experimented with using a fixed penalty parameter 
of 1.4 for the lasso, which was chosen to achieve specificity more similar to that of the 
Bayesian methods, with the caveat that such a fixed choice for the penalty parameter is only 
possible in the context of a simulation study. Unsurprisingly, we found that a stronger 
penalty improves specificity, but degrades prediction. For example, in Model 1, fixing the 
penalty parameter to 1.4 improves specificity to 0.989, but worsens the PMSE to 47.7, much 
higher than when using parameters chosen using cross-validation, possibly due to 
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overshrinkage of the coefficients when using the stronger penalty. As compared to standard 
Bayesian variable selection, the joint approach improves sensitivity due to greater ability to 
detect small effects acting within pathways, and also offers small improvements in 
specificity. To assess the tradeoff between sensitivity and specificity, we rely on both the 
MCC, which provides a single measure to assess variable selection accuracy conditional on 
model selection, and the AUC, which provides a summary of the trade-off between 
sensitivity and specificity across a range of model sizes. The proposed joint method is either 
best or very close to best on these metrics across all models, and also achieves the lowest 
PMSE across the methods compared.
Although our primary focus in comparison of methods is accuracy of variable selection, we 
found that the accuracy of graph structure learning for the proposed joint model was quite 
high across all simulation settings, with an average true positive rate for edge detection of 
0.998 and average false positive rate of 3.6e-4. Since there are p · (p − 1)/2 – 200 missing 
edges in the graph, the corresponds to an average of 10.3 false positive edge selections.
In this section, we have demonstrated that when the network structure is relevant to the set 
of predictors influencing the outcome, the proposed joint model outperforms standard 
Bayesian variable selection in terms of both selection and prediction accuracy. We also 
provide a comparison in the Supplement demonstrating that when the predictors are 
independent, the two methods perform similarly along these metrics, so that while there is 
no advantage to applying the joint model to non-network related predictors, it does not 
degrade performance.
5. Case study
In this section, we utilize the proposed method to examine the impact of protein levels on 
glioblastoma survival. Specifically, we obtained protein measurements for glioblastoma 
patients assayed via reverse phase protein arrays (RPPA) from The Cancer Proteome Atlas 
(TCPA) [42]. This data is available online at http://app1.bioinformatics.mdanderson.org/
tcpa/design/basic/index.html. The data set includes quantifications for 187 proteins for 215 
subjects. For 212 of these subjects, we were able to obtain clinical data including age, sex 
and survival times, from The Cancer Genome Atlas (TCGA), available online at http://
cancergenome.nih.gov. For 159 subjects, the number of days to death was recorded, while 
the remaining survival events are right-censored, so the reported times correspond to days to 
last contact. This data set is a logical setting for the application of our proposed joint graph 
and variable selection method since proteins typically interact within signaling pathways, 
and the entire pathway, rather than a single protein, can influence disease progression. 
Although there is a large amount of reference information on protein interactions from 
databases such as KEGG, these data represent different (typically healthy) conditions, which 
may not be relevant to the population of glioblastoma patients.
To model this data, we follow the accelerated failure time (AFT) model discussed in Section 
2.7, using standardized data with age and sex as fixed covariates. In order to assess 
performance, we split the data into a training set of size ntrain = 175 and test set of size ntest 
= 37. We chose to use an uneven split with more subjects in the training set than the test set 
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to allow better model selection given the complexity of the problem. We compare two 
inference approaches: standard Bayesian variable selection and the proposed joint variable 
and network selection method. We do not include a comparison to the regularized methods 
as the Glmnet software does not implement the AFT model. In addition, we do not assume 
that relevant prior network information is available, as is required for the method of Li and 
Li.
Both Bayesian methods require the choice of prior hyperparameters. Following the guidance 
in Sections 2.3 and 2.6, we use hα = hβ = 1 since the data are standardized, and h0 = 1 × 106. 
To compensate for the somewhat weaker signal vs. in the simulated data, for standard 
Bayesian variable selection we use a prior probability of variable inclusion of 0.2, and for 
the joint method, we set the parameter α to -1.75. This corresponds to a prior probability of 
variable selection of around 0.15 when either b = 0 or we have an empty graph. We set b to 
0.5 as in the simulation, which has the effect of increasing the prior probability of variable 
inclusion given that the variable is connected in the graph.
As is commonly seen in real biological data, the degree of correlation among the protein 
measurements is quite high, in contrast to the simulation setting, in which most variables 
were truly independent. Since it is biologically likely that most proteins only interact with a 
limited number of other proteins, we increase the prior parameters ν0 and ν1 vs. the setting 
used in simulation in order to achieve a reasonably sparse graph. This adjustment allows us 
to focus on the strongest connections which are best supported by the data. Specifically, we 
set v0 to 0.6 and v1 to 360. Although these values are larger than those used in the simulation 
study, they are still within the range recommended by Wang [35] as providing good mixing 
and convergence. We retain the settings λ = 1 and π = 2/(p − 1) used in the simulation 
section.
For both variable selection approaches, we carried out MCMC simulations on the training 
data, performing 10,000 iterations burn-in followed by 10,000 iterations as the basis for 
inference. We then used these results to predict log survival times for the test data following 
the general idea of equations (14) and (15), modified to use the MCMC estimate of the latent 
value Y and to include the fixed covariates and intercept. The predicted survival times were 
evaluated on the basis of two metrics: the integrated Brier score [43] and the concordance 
index [44]. The integrated Brier score (IBS) measures the gap between the true and 
estimated survival curves, making scores closer to 0 the best. We compute the Brier score at 
time t as
(16)
where  is the observed (possibly censored) time for subject i, Ĝ is the Kaplan-Meier 
estimate of the censoring distribution for subjects i = 1,…, ntest, and Ŝi(t) is the probability 
of subject i being alive at time t based on the survivor function estimated following Sha, 
Tadesse and Vannucci [37]. The integrated Brier score is simply the integral of the Brier 
score from time 0 to the maximum survival time :
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(17)
where tmax is the maximum survival time in the test data set. Our second metric, the 
concordance index (C-index), measures the proportion of pairs of subjects with observed 
survival times where the predictions are concordant with the truth in terms of which subject 
survived longer. Scores close to 1 are therefore best for this metric. The C-index is 
computed as
(18)
where t̂i and t̂j are the predicted survival times for subjects i and j, Φ is the set of pairs (i, j) 
such that  and δj = 1, and |Φ| is the number of such pairs. For more discussion on the 
evaluation of survival models, see Hielscher et al. [45].
Using standard Bayesian variable selection, three proteins were identified as relevant to 
survival: Bcl-2, paxillin, and rictor-pT1135. The “p” suffix denotes phosphorylation at the 
given site. The proportion of selected variables is quite a bit lower than the prior probability 
of variable inclusion, suggesting that the signal in the data is fairly weak. Using the joint 
model, six proteins were selected: beta-catenin, c-Met-pY1235, CD20, Chk2-pT68, 
heregulin, and rictor-pT1135. Although the joint method had more proteins with high 
posterior probability (> 0.5), the two methods had a very similar number of proteins with 
posterior probability > 0.2 (18 for standard Bayesian variable selection vs. 17 for the joint 
method), suggesting that the prior calibration was reasonable. The proposed joint model 
performed better in terms of prediction using both metrics, suggesting that the larger number 
of discoveries may reflect improved power. It achieved a lower IBS of 0.12 vs. 0.14 for 
standard Bayesian variable selection, and a greater C-index of 0.77, in contrast to 0.74 for 
standard Bayesian variable selection. While this improvement provides some validation of 
the proposed method, it's difficult to assess its significance. In this context, where the 
sample size is limited and independent training sets are not available, it's not possible to 
obtain valid estimates of the prediction error. The results from the joint method also provide 
insight into coordinated effects of network-related proteins. The posterior selected graph 
among all proteins includes 230 edges, corresponding to an average node degree of around 
2.5. Among the 6 selected proteins, 4 were linked to each other through the line graph Chk2-
pT68 – c-Met-pY1235 – CD20 – heregulin. Figure 1, which was produced using the 
Rgraphviz package [46], shows the selected predictors in the context of the full network 
inferred. Of the two proteins with no edges to other selected variables, rictor-pT1135 was 
also chosen using standard Bayesian variable selection, indicating that it may exert a strong 
influence independent of network effects. The additional proteins identified by the joint 
model appear to be meaningful. CD20, for example, has previously been discovered as a 
prognostic factor for leukemia and ovarian cancer [47, 48]. The inferred connections seem 
plausible as well. For example, Chk2, which is part of the DNA damage response pathway, 
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is involved in the activation of transcription factors which regulate c-Met [49], and both 
Chk2 and c-Met have been implicated in glioblastoma survival [50, 51].
6. Conclusion
In this work, we have developed a novel modeling strategy to simultaneously select 
network-structured variables and learn the network relating them. Our approach is fully 
Bayesian, and therefore allows us to account for uncertainty over both the variable and 
graph selections. Through simulations, we have demonstrated that this approach can achieve 
improved selection and prediction accuracy over competing variable selection methods. We 
have illustrated this method with an application to identify proteins and their interactions 
which impact glioblastoma survival. The proposed method is well-suited to other biological 
applications where genes, proteins or metabolites exert coordinated effects within pathways, 
and can accommodate outcomes which are continuous, binary, multinomial, or survival.
We have found our method to provide satisfactory results in settings with around 200 to 300 
preselected markers. As more computationally efficient approaches for Bayesian estimation 
of Gaussian graphical models are developed, these can easily be merged into our framework, 
enabling the analysis of a much larger number of predictors. Although we have chosen to 
model protein interactions via undirected networks in this paper, a similar approach can be 
taken when the interactions between predictors are better represented by other types of 
networks such as directed networks or chain graphs. Additional future developments will 
include the extension of our approach to more complex models, such semi-parametric 
regression and more flexible models for time-to-event endpoints. Finally, we would like to 
consider modificiations to accommodate non-normal predictors. Under the proposed model, 
some deviation from Gaussianity is acceptable: for example, we found that the joint model 
performed similarly to other methods in terms of variable selection accuracy and prediction 
when the predictors were drawn from a multivariate t-distribution with scale matrix Σ and 5 
degrees of freedom. For data which are strongly non-normal, however, alternative 
approaches for network inference would be of interest. In particular, although there has been 
some work done on robust Gaussian graphical models in the frequentist literature [52, 53], 
there has been little work in the Bayesian framework. The only proposed Bayesian approach 
[54], while more robust to outliers than the model developed here, has significant 
disadvantages in that it is much more computationally expensive and requires restrictive 
assumptions on the graph structure. Developing a more scalable and flexible approach for 
robust graphical modeling would therefore be of interest in future work.
Software
The Matlab implementations of the linear, probit, and AFT models have been made 
available on the author's website. For the simulation in Section 4, which includes 240 
predictor variables, it takes about 2 hours to run 10,000 MCMC iterations in Matlab Release 
2012b. The IBS and C-index, which were used to measure prediction performance under the 
AFT model in Section 5, were computed using the Matlab code provided as supporting 
information to Chekouo et al. [55].
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Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
Christine Peterson's research has been funded by the NIH/NCI T32 Pre-Doctoral Training Program in Biostatistics 
for Cancer Research (NIH Grant NCI T32 CA096520), by a training fellowship from the Keck Center of the Gulf 
Coast Consortia, on the NLM Training Program in Biomedical Informatics, National Library of Medicine (NLM) 
T15LM007093, by a postdoctoral fellowship from the Center for Computational, Evolutionary and Human 
Genomics (CEHG) at Stanford University, and by NIH grant MH101782. Francesco Stingo is partially supported 
by a Cancer Center Support Grant (NCI Grant P30 CA016672). Marina Vannucci's research is partially funded by 
NIH/NHLBI P01-HL082798.
References
1. Markowetz F, Spang R. Inferring cellular networks – a review. BMC Bioinformatics. 2007; 8(Suppl 
6):S5.10.1186/1471-2105-8-S6-S5 [PubMed: 17903286] 
2. Wolfe CJ, Kohane IS, Butte AJ. Systematic survey reveals general applicability of “guilt-by-
association” within gene coexpression networks. BMC Bioinformatics. 2005; 6(1):
227.10.1186/1471-2105-6-227 [PubMed: 16162296] 
3. Werhli AV, Grzegorczyk M, Husmeier D. Comparative evaluation of reverse engineering gene 
regulatory networks with relevance networks, graphical gaussian models and bayesian networks. 
Bioinformatics. 2006; 22(20):2523–2531.10.1093/bioinformatics/btl391 [PubMed: 16844710] 
4. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, Sklar P, et al. 
Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 
2009; 460(7256):748–752.10.1038/nature08185 [PubMed: 19571811] 
5. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, Pirruccello JP, 
et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 2010; 
466(7307):707–713.10.1038/nature09270 [PubMed: 20686565] 
6. Allen HL, Estrada K, Lettre G, Berndt SI, Weedon MN, Rivadeneira F, Willer CJ, et al. Hundreds 
of variants clustered in genomic loci and biological pathways affect human height. Nature. 2010; 
467(7317):832–838.10.1038/nature09410 [PubMed: 20881960] 
7. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, 
Pomeroy SL, Golub T, Lander ES, Mesirov JP. Gene set enrichment analysis: a knowledge-based 
approach for interpreting genome-wide expression profiles. Proceedings of the National Academy 
of Sciences. 2005; 102(43):15545–15550.10.1073/pnas.0506580102
8. Li C, Li H. Network-constrained regularization and variable selection for analysis of genomic data. 
Bioinformatics. 2008; 24(9):1175–1182.10.1093/bioinformatics/btn081 [PubMed: 18310618] 
9. Li C, Li H. Variable selection and regression analysis for graph-structured covariates with an 
application to genomics. Annals of Applied Statistics. 2010; 4(3):1498–1516.10.1214/10-AOAS332 
[PubMed: 22916087] 
10. Pan W, Xie B, Shen X. Incorporating predictor network in penalized regression with application to 
microarray data. Biometrics. 2010; 66(2):474–484.10.1111/j.1541-0420.2009.01296.x [PubMed: 
19645699] 
11. Huang J, Ma S, Li H, Zhang C. The sparse Laplacian shrinkage estimator for high-dimensional 
regression. Annals of Statistics. 2011; 39(4):2021–2046. [PubMed: 22102764] 
12. Kim S, Pan W, Shen X. Network-based penalized regression with application to genomic data. 
Biometrics. 2013; 69(3):582–593.10.1111/biom.12035 [PubMed: 23822182] 
13. Li F, Zhang NR. Bayesian variable selection in structured high-dimensional covariate spaces with 
applications in genomics. Journal of the American Statistical Association. 2010; 105(491):1202–
1214.10.1198/jasa.2010.tm08177
14. Stingo FC, Vannucci M. Variable selection for discriminant analysis with Markov random field 
priors for the analysis of microarray data. Bioinformatics. 2011; 27(4):495–501.10.1093/
bioinformatics/btq690 [PubMed: 21159623] 
Peterson et al. Page 17
Stat Med. Author manuscript; available in PMC 2017 March 30.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
15. Stingo FC, Chen YA, Tadesse MG, Vannucci M. Incorporating biological information into linear 
models: a Bayesian approach to the selection of pathways and genes. Annals of Applied Statistics. 
2011; 5(3):1978–2002.10.1214/11-AOAS463 [PubMed: 23667412] 
16. Peng B, Zhu D, Ander BP, Zhang X, Xue F, Sharp FR, Yang X. An integrative framework for 
Bayesian variable selection with informative priors for identifying genes and pathways. PloS One. 
2013; 8(7):e67672.10.1371/journal.pone.0067672 [PubMed: 23844055] 
17. Hill SM, Neve RM, Bayani N, Kuo W, Ziyad S, Spellman PT, Gray JW, Mukherjee S. Integrating 
biological knowledge into variable selection: an empirical Bayes approach with an application in 
cancer biology. BMC Bioinformatics. 2012; 13:94.10.1186/1471-2105-13-94 [PubMed: 
22578440] 
18. Zhou H, Zheng T. Bayesian hierarchical graph-structured model for pathway analysis using gene 
expression data. Statistical Applications in Genetics and Molecular Biology. 2013; 12(3):393–
412.10.1515/sagmb-2013-0011 [PubMed: 23735434] 
19. Dobra A. Variable selection and dependency networks for genomewide data. Biostatistics. 2009; 
10(4):621–639.10.1093/biostatistics/kxp018 [PubMed: 19520789] 
20. Liu F, Chakraborty S, Li F, Liu Y, Lozano AC. Bayesian regularization via graph Laplacian. 
Bayesian Analysis. 2014; 9(2):449–474.10.1214/14-BA860
21. Tibshirani R. Regression shrinkage and selection via the lasso. Journal of the Royal Statistical 
Society: Series B (Statistical Methodology). 1996; 58(1):267–288.
22. George EI, McCulloch RE. Approaches for Bayesian variable selection. Statistica Sinica. 1997; 
7(2):339–374.
23. Dempster A. Covariance selection. Biometrics. 1972; 28(1):157–175.
24. Meinshausen N, Bühlmann P. High-dimensional graphs and variable selection with the lasso. 
Annals of Statistics. 2006; 34(3):1436–1462.10.1214/009053606000000281
25. Yuan M, Lin Y. Model selection and estimation in the Gaussian graphical model. Biometrika. 
2007; 94(1):19–35.10.1093/biomet/asm018
26. Friedman J, Hastie T, Tibshirani R. Sparse inverse covariance estimation with the graphical lasso. 
Biostatistics. 2008; 9(3):432–441.10.1093/biostatistics/kxm045 [PubMed: 18079126] 
27. Roverato A. Hyper inverse Wishart distribution for non-decomposable graphs and its application to 
Bayesian inference for Gaussian graphical models. Scandinavian Journal of Statistics. 2002; 29(3):
391–411.10.1111/1467-9469.00297
28. Atay-Kayis A, Massam H. A Monte Carlo method for computing the marginal likelihood in 
nondecomposable Gaussian graphical models. Biometrika. 2005; 92(2):317–335.10.1093/biomet/
92.2.317
29. Dobra A, Lenkoski A, Rodriguez A. Bayesian inference for general Gaussian graphical models 
with application to multivariate lattice data. Journal of the American Statistical Association. 2011; 
106(496):1418–1433.10.1198/jasa.2011.tm10465
30. Wang H, Li S. Efficient Gaussian graphical model determination under G-Wishart prior 
distributions. Electronic Journal of Statistics. 2012; 6:168–198.10.1214/12-EJS669
31. Lenkoski A. A direct sampler for G-Wishart variates. Stat. 2013; 2(1):119–128.10.1002/sta4.23
32. Wang H. Bayesian graphical lasso models and efficient posterior computation. Bayesian Analysis. 
2012; 7(4):867–886.10.1214/12-BA729
33. Peterson C, Vannucci M, Karakas C, Choi W, Ma L, Maletić-Savatić M. Inferring metabolic 
networks using the Bayesian adaptive graphical lasso with informative priors. Statistics and its 
Interface. 2013; 6(4):547–558.10.4310/SII.2013.v6.n4.a12 [PubMed: 24533172] 
34. Peterson C, Stingo FC, Vannucci M. Bayesian inference of multiple Gaussian graphical models. 
Journal of the American Statistical Association. 2015; 110(509):159–174. [PubMed: 26078481] 
35. Wang H. Scaling it up: stochastic search structure learning in graphical models. Bayesian Analysis. 
2015; 10(2):351–377.10.1214/14-BA916
36. Sha N, Vannucci M, Tadesse MG, Brown PJ, Dragoni I, Davies N, Roberts TC, Contestabile A, 
Salmon M, Buckley C, Falciani F. Bayesian variable selection in multinomial probit models to 
identify molecular signatures of disease stage. Biometrics. 2004; 60:812–819.10.1111/j.
0006-341X.2004.00233.x [PubMed: 15339306] 
Peterson et al. Page 18
Stat Med. Author manuscript; available in PMC 2017 March 30.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
37. Sha N, Tadesse MG, Vannucci M. Bayesian variable selection for the analysis of microarray data 
with censored outcomes. Bioinformatics. 2006; 22(18):2262–2268.10.1093/bioinformatics/btl362 
[PubMed: 16845144] 
38. Barbieri M, Berger J. Optimal predictive model selection. Annals of Statistics. 2004; 32(3):870–
897.10.1214/009053604000000238
39. Brown PJ, Vannucci M, Fearn T. Multivariate Bayesian variable selection and prediction. Journal 
of the Royal Statistical Society: Series B (Statistical Methodology). 1998; 60(3):627–
641.10.1111/1467-9868.00144
40. Zou H, Hastie T. Regularization and variable selection via the elastic net. Journal of the Royal 
Statistical Society: Series B (Statistical Methodology). 2005; 67(2):301–320.
41. Smith AF. A general Bayesian linear model. Journal of the Royal Statistical Society: Series B 
(Methodological). 1973; 35(1):67–75.
42. Li J, Lu Y, Akbani R, Ju Z, Roebuck PL, Liu W, Yang J, Broom BM, Verhaak RG, Kane DW, et 
al. TCPA: a resource for cancer functional proteomics data. Nature Methods. 2013; 10(11):1046–
1047.10.1038/nmeth.2650 [PubMed: 24037243] 
43. Graf E, Schmoor C, Sauerbrei W, Schumacher M. Assessment and comparison of prognostic 
classification schemes for survival data. Statistics in Medicine. 1999; 18(17-18):2529–2545. 
[PubMed: 10474158] 
44. Harrell, FE. Springer Series in Statistics. Springer; New York: 2001. Regression modeling 
strategies: with applications to linear models, logistic regression, and survival analysis. 
45. Hielscher T, Zucknick M, Werft W, Benner A. On the prognostic value of survival models with 
application to gene expression signatures. Statistics in Medicine. 2008; 29(7-8):818–829.10.1002/
sim.3768 [PubMed: 20213714] 
46. Gentry J, Long L, Gentleman R, Falcon S, Hahne F, Sarkar D, Hansen KD. Rgraphviz: provides 
plotting capabilities for R graph objects. R package version 2.6.0. 
47. Thomas DA, O'Brien S, Jorgensen JL, Cortes J, Faderl S, Garcia-Manero G, Verstovsek S, Koller 
C, Pierce S, Huh Y, et al. Prognostic significance of CD20 expression in adults with de novo 
precursor B-lineage acute lymphoblastic leukemia. Blood. 2009; 113(25):6330–6337.10.1182/
blood-2008-04-151860 [PubMed: 18703706] 
48. Milne K, Köbel M, Kalloger SE, Barnes RO, Gao D, Gilks CB, Watson PH, Nelson BH. 
Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, 
FoxP3 and TIA-1 as positive prognostic factors. PLoS One. 2009; 4:e6412.10.1371/journal.pone.
0006412 [PubMed: 19641607] 
49. Rivera M, Sukhdeo K, Yu JS. Ionizing radiation in glioblastoma initiating cells. Frontiers in 
Oncology. 2013; 3:1–6.10.3389/fonc.2013.00074 [PubMed: 23373009] 
50. Squatrito M, Brennan CW, Helmy K, Huse JT, Petrini JH, Holland EC. Loss of ATM/Chk2/p53 
pathway components accelerates tumor development and contributes to radiation resistance in 
gliomas. Cancer Cell. 2010; 18(6):619–629.10.1016/j.ccr.2010.10.034 [PubMed: 21156285] 
51. Kong D, Song S, Kim D, Joo KM, Yoo J, Koh JS, Dong SM, Suh Y, Lee J, Park K, et al. 
Prognostic significance of c-Met expression in glioblastomas. Cancer. 2009; 115(1):140–
148.10.1002/cncr.23972 [PubMed: 18973197] 
52. Finegold M, Drton M. Robust graphical modeling of gene networks using classical and alternative 
t-distributions. The Annals of Applied Statistics. 2011; 5(2A):1057–1080.10.1214/10-AOAS410
53. Sun H, Li H. Robust Gaussian graphical modeling via l1 penalization. Biometrics. 2012; 68(4):
1197–1206.10.1111/j.1541-0420.2012.01785.x [PubMed: 23020775] 
54. Finegold M, Drton M. Robust Bayesian graphical modeling using Dirichlet t-distributions. 
Bayesian Analysis. 2014; 9(3):521–550.10.1214/13-BA856
55. Chekouo T, Stingo FC, Doecke JD, Do K. miRNA-target gene regulatory networks: a Bayesian 
integrative approach to biomarker selection with application to kidney cancer. Biometrics. 
201510.1111/biom.12266
Peterson et al. Page 19
Stat Med. Author manuscript; available in PMC 2017 March 30.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 1. 
Inferred network for the glioblastoma case study given in Section 5. The graph includes 230 
connections among the 187 proteins under study. Proteins selected by the joint model only 
are marked in blue, proteins selected by standard Bayesian variable selection are marked in 
red, and proteins selected under both are marked in purple. Labels are provided for all 
selected proteins and their neighbors in the graph.
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